Literature DB >> 19501882

Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.

Roberta Mazzucchelli1, Francesca Barbisan, Alfredo Santinelli, Marina Scarpelli, Andrea B Galosi, Antonio Lopez-Beltran, Liang Cheng, Ziya Kirkali, Rodolfo Montironi.   

Abstract

OBJECTIVES: To ascertain which variables of bladder urothelial carcinoma (UC) might be useful in predicting either UC involving the prostate (UCP) or incidental prostate adenocarcinoma in radical cystoprostatectomy specimens.
METHODS: The bladder and whole-mount prostate sections of 248 radical cystoprostatectomy specimens were reviewed. Stepwise discriminant analysis was used to predict UCP or incidental prostate adenocarcinoma.
RESULTS: UCP was present in 94 patients (37.9%). UC originated from the prostatic urethra and periurethral ducts in 78 (31.45%), and isolated direct extension of UC from the bladder was present in 16 patients (6.45%). The periurethral ducts coexisted with direct extension of bladder UC in 11 patients (4.4%). Prostate adenocarcinoma was identified in 123 patients (49.6%). Carcinoma in situ and high-grade urothelial papillary carcinoma were seen in 8 (3.2%) and 5 (2.0%) patients, respectively. In 57 (23%), 64 (25.8%), and 87 (35.1%) patients, UC had invaded the subepithelial connective tissue, muscularis propria, and perivesical tissue, respectively. UC was multifocal in 53 patients (21.4%). The tumor was in the trigone and bladder neck in 160 patients (64.5%). Of the 248 patients, 98 (39.5%) had a history of recurrence. Stepwise discriminant analysis selected 3 variables of bladder UC (previous recurrence and location and number of foci) and correctly predicted the group in 72.2% of patients without and with UCP. Discriminant analysis selected 2 variables of bladder UC (focality and previous recurrence) and correctly predicted the group in 57.7% of patients without and with prostate adenocarcinoma.
CONCLUSIONS: Our approach can identify bladder UC variables that could guide urologists in the selection of the most appropriate surgical procedure.

Entities:  

Mesh:

Year:  2009        PMID: 19501882     DOI: 10.1016/j.urology.2009.03.010

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  9 in total

1.  Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer.

Authors:  Koji Ichihara; Hiroshi Kitamura; Naoya Masumori; Fumimasa Fukuta; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2011-11-08       Impact factor: 3.402

Review 2.  Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.

Authors:  Georgios Gakis; Peter C Black; Bernard H Bochner; Stephen A Boorjian; Arnulf Stenzl; George N Thalmann; Wassim Kassouf
Journal:  Eur Urol       Date:  2016-10-06       Impact factor: 20.096

3.  Full analysis of the prostatic urethra at the time of radical cystoprostatectomy for bladder cancer: impact on final disease stage.

Authors:  Justine Varinot; Philippe Camparo; Morgan Roupret; Marc Olivier Bitker; Fréderique Capron; Olivier Cussenot; J Alfred Witjes; Eva Compérat
Journal:  Virchows Arch       Date:  2009-10-20       Impact factor: 4.064

4.  Incidentally found prostate cancer and influence on overall survival after radical cystoprostatectomy.

Authors:  Algimantas Sruogis; Albertas Ulys; Giedre Smailyte; Zygimantas Kardelis; Arunas Kulboka; Giedre Anglickienė; Nerimantas Samalavicius; Marius Anglickis
Journal:  Prostate Cancer       Date:  2012-06-03

5.  Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens.

Authors:  Berna Aytac; Hakan Vuruskan
Journal:  World J Surg Oncol       Date:  2011-07-20       Impact factor: 2.754

6.  Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy.

Authors:  Marco Moschini; Francesco Soria; Martin Susani; Stephan Korn; Alberto Briganti; Morgan Roupret; Christian Seitz; Killian Gust; Andrea Haitel; Francesco Montorsi; Gregory Wirth; Brian D Robinson; Pierre I Karakiewicz; Mehmet Özsoy; Michael Rink; Shahrokh F Shariat
Journal:  Bladder Cancer       Date:  2017-07-27

7.  Prostatic urethra recurrence after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC).

Authors:  Vladimir Bilim; Senji Hoshi
Journal:  Clin Case Rep       Date:  2022-01-08

8.  A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder.

Authors:  Ranlu Liu; Xiaoqiang Xie; Zhihong Zhang; Yong Xu
Journal:  Eur J Med Res       Date:  2013-10-03       Impact factor: 2.175

9.  Undiagnosed prostatic malignancy at the time of radical cystoprostatectomy after prior prostatic radiation therapy.

Authors:  Pranav Sharma; Kamran Zargar-Shoshtari; Philippe E Spiess; Wade J Sexton; Michael A Poch
Journal:  Urol Ann       Date:  2016 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.